MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > MEDMIRA NEEDS TO RELEASE NEWS BEFORE MORNING

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Feb 08, 2024 1:56pm

129 Views

Post# 35870516

RE:MEDMIRA NEEDS TO RELEASE NEWS BEFORE MORNING

If no release possible then they will further the dim view some have of the company if they do not address the rising skepticism some or many of Medmira’s actions omissions comments and strategies are generating

<< Previous

Bullboard Posts

Next >>

Corus reports Q1 profit drop in the face of falling revenue